Author

G. Soler Gonzalez

Observed name: gonzalo gonzalez

Institutions: Universitat Autònoma de Barcelona, Houston Methodist, Institut Català d'Oncologia, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Observed institutions: Universitat Autònoma de Barcelona, Houston Methodist, Institut Català d'Oncologia, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Duran i Reynals Hospital

OpenAlex ID: A5000397708

595P The DUREC trial: Durvalumab plus total neoadjuvant therapy in locally advanced rectal cancer - a multicenter, single-arm, phase II study (GEMCAD-1703)

2023 · J. Capdevila Castillon, V. Alonso, et al. · Annals of Oncology · 9

408P Prediction of survival using the G8 scale frailty scale in a prospective series of elderly patients with colon cancer

2022 · G. Soler Gonzalez, L. Raventos, et al. · Annals of Oncology · 1

300P Development and implementation of an application (APP) for monitoring and managing symptoms during oxaliplatin-based chemotherapy (CT) in patients with colorectal cancer (CRC): APP OXA

2025 · A. Plaja Salarich, C. Buges, et al. · ESMO Real World Data and Digital Oncology

283P Incidence of male breast cancer in genetically high-risk patients

2025 · G. Zatta Cobos, I. Teruel-Garcia, et al. · ESMO Open

Abstract 6113: Cytotoxic and antitumoral effect of an anti-CD44v6 CAR-T against gastric cancer

2025 · gonzalo gonzalez, Moonsoo Jin, et al. · Cancer Research

84P Next-generation sequencing (NGS) in metastatic colorectal cancer (mCRC): Clinical utility in daily practice in a comprehensive cancer centre

2024 · J.C. Ruffinelli Rodriguez, M. Balsa Pena, et al. · Annals of Oncology

106P Clinical application of next-generation sequencing in metastatic colorectal cancer (mCRC): Experience from a comprehensive cancer centre

2023 · D. Lluís Garulo, J.C. Ruffinelli, et al. · ESMO Open

Works count: 7

Citation count: 10

H-index: 1

I10-index: